CD8A and melanoma: Interestingly, tumor tissue samples showing a higher percentage of CD8+ cells and lower abundance of MITF+ melanoma cells were taken post-treatment (Figure 4, purple dots), suggesting that DC vaccination or ipilimumab has enhanced immunoreactivity against these cells.